Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MRTX > SEC Filings for MRTX > Form 8-K on 16-Jun-2016All Recent SEC Filings

Show all filings for MIRATI THERAPEUTICS, INC.

Form 8-K for MIRATI THERAPEUTICS, INC.


16-Jun-2016

Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ


Item 5.03 Amendments to Articles of Incorporation or
Bylaws; Change in Fiscal Year.

On June 16, 2016, the Board of Directors of Mirati Therapeutics, Inc. (the "Company") adopted an amendment (the "Amendment") to the Company's Bylaws (the "Bylaws"), effective immediately, to add a new Article XV, Section 47 to the Bylaws. The new provision provides that, unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company; (ii) any action asserting a claim of breach of a fiduciary duty owed by any of the Company's directors, officers or other employees to the Company or the Company's stockholders; (iii) any action asserting a claim against the Company or any director or officer or other employee of the Company arising pursuant to any provision of the Delaware General Corporation Law, the Company's certificate of incorporation or the Bylaws; or (iv) any action asserting a claim against the Company or any director or officer or other employee of the Company governed by the internal affairs doctrine.

The foregoing summary of the Amendment is qualified in its entirety by reference to the complete text of the Amendment, a copy of which is attached to this Current Report on Form 8-K as Exhibit 3.1.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
No. Description

3.1 Amendment to Bylaws of Mirati Therapeutics, Inc.


  Add MRTX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MRTX - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.